Nitric oxide and arginine.
Vallance
P
P
Centre for Clinical Pharmacology and Therapeutics, University College London, UK. patrick.vallance@ucl.ac.uk
D000581:Amidohydrolases; D000818:Animals; D001120:Arginine / Q000502:physiology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D006867:Hydrolases / Q000037:antagonists & inhibitors; D007700:Kinetics; D008956:Models, Chemical; D009569:Nitric Oxide / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D052250:Nitric Oxide Synthase Type III; D019323:omega-N-Methylarginine / Q000494:pharmacology
D004791:Enzyme Inhibitors; D019323:omega-N-Methylarginine; D009569:Nitric Oxide; D001120:Arginine; C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III; D006867:Hydrolases; D000581:Amidohydrolases; C059999:dimethylargininase